Reply: RE: Reyes A, Revil C, Niggli M, et al. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. Curr Med Res Opin. 2019;35(12):2079-2087.
2020
Dear Editor,We thank Jain and Lethagen for the opportunity to clarify some points of interest.As outlined in Mahlangu et al.1, emicizumab prophylaxis has demonstrated a statistically significant an...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
4
References
0
Citations
NaN
KQI